Skip to search formSkip to main contentSkip to account menu

Melacine

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Cancer VaccinesMelanoma Theraccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Therapeutic vaccine for melanoma: the untouched grail?
Evaluation of: Mitchell MS, Abrams J, Thompson JA et al. Randomized trial of an allogeneic melanoma lysate vaccine with low-dose… 
2004
2004
Significant impact of HLA class I allele expression on outcome in melanoma patients treated with an allogeneic melanoma cell lysate vaccine. Final analysis of SWOG-9035.
7501 Background: SWOG-9035 compared 2 years of an allogeneic melanoma lysate (Melacine™) to observation in patients (pts) with… 
Review
2003
Review
2003
Immunotherapy as part of combinations for the treatment of cancer.
Review
2002
Review
2002
Cancer vaccines, a critical review--Part I.
Cancer vaccines are more properly referred to as 'active specific immunotherapy', and are used to treat cancers rather than to… 
2002
2002
Issues in the Clinical Development of Investigational Agents Being Evaluated for the Post-surgical Adjuvant Treatment of High-Risk ( Stages IIb and III ) Melanoma
  • 2002
  • Corpus ID: 32613938
2001
2001
Corixa's melanoma vaccine [`Melacine'] has been launched in Canada
  • 2001
  • Corpus ID: 195152251
Review
2000
Review
2000
Melanoma. A multidisciplinary approach for the general surgeon.
2000
2000
A melanoma vaccine [`Melacine'] appears to be beneficial in patients with malignant melanoma,
  • 2000
  • Corpus ID: 195156641
1997
1997
Phase III trial of melacine?? melanoma theraccine versus combination chemotherapy in the treatment of stage IV melanoma: 179
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)